|
|
Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/1742
|
| Title: | Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. |
| Authors: | Oyugi, Jessica H.
Byakika-Tusiime, Jayne
Charlebois, Edwin D.
Kityo, Cissy
Mugerwa, Roy
Mugyenyi, Peter
Bangsberg, David R. |
| Keywords: | HIV/AIDS
Adherence
Generic HIV
Viral load suppression
Antiretroviral Therapy
Uganda |
| Issue Date: | 2004 |
| Publisher: | Lippincott Williams & Wilkins |
| Citation: | Oyugi, J.H., Byakika-Tusiime, J., Charlebois, E.D., Kityo, C., Mugerwa, R., Mugyenyi, P., Bangsberg, D.R. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes, 36(5) |
| Abstract: | Background: There are no validated measures of adherence to HIV antiretroviral therapy in resource-poor settings. Such measures are essential to understand the unique barriers to adherence as access to HIV antiretroviral therapy expands.
Methods: We assessed correspondence between multiple measures of adherence and viral load suppression in 34 patients purchasing generic Triomune antiretroviral therapy (coformulated stavudine, lamivudine, and nevirapine; CIPLA, Ltd., Mumbai, India) in Kampala, Uganda. Measures included 3-day patient self-report, 30-day visual analog scale, electronic medication monitoring, and unannounced home pill count. HIV-1 load was determined at baseline and 12 weeks.
Results: Mean adherence was 91%–94% by all measures. Seventysix percent of subjects had a viral load of <400 copies/mL at 12 weeks. All measures were closely correlated with each other (R = 0.77–0.89). Each measure was also significantly associated with 12-week HIV load. There was no significant difference between patient-reported and objective measures of adherence.
Conclusions: This sample of patients purchasing generic HIV antiretroviral therapy has among the highest measured adherence reported to date. Patient-reported measures were closely associated with objective measures. The relative ease of administration of the 30-day visual analog scale suggests that this may be the preferred method to assess adherence in resource-poor settings. |
| URI: | http://hdl.handle.net/123456789/1742 |
| ISSN: | 1525-4135 |
| Appears in Collections: | Research Articles (Health-Sciences)
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| oyugi-tusiime-chs-res.pdf | | 59Kb | Adobe PDF | View/Open |
|
All items in DSpace are protected by copyright, with all rights reserved.
|
